ESR1 and atherosclerosis: It was also an estrogen receptor modulator, which could improve atherosclerosis in postmenopausal mice by inhibiting inflammation and apoptosis and activating the G protein-coupled estrogen receptor (GPER) and PI3K/AKT/Nrf2 pathway [21].